Analysts’ Viewpoint on Global Market Scenario
There is an increasing demand for nebulizers across the globe due to the rising prevalence of respiratory disorders such as asthma, COPD, and cystic fibrosis. Technological advancements in healthcare devices, lucrative presence of international as well as regional players, and rising geriatric patients all over the world are contributing to the market growth. Environmental pollution, smoking, and changing lifestyles are some of the factors contributing to the growing issues of respiration. Companies in the global nebulizers business should accelerate their product development to obtain competitive benefits. However, drug loss during delivery is likely to hamper the growth of the global market for nebulizers during the forecast period.
The emergence of advanced manufacturing processes is creating beneficial opportunities for device manufacturers. Technological advancements in respiratory medical devices are expected to drive the global nebulizer market during the forecast period. Manufacturers operating in the global nebulizers market are increasing their product portfolio to meet the demands of the healthcare sector.
Respiratory diseases are increasing among individuals due to which they are highly dependent on various inhaling devices such as nebulizers to provide them ease of breathing. Moreover, asthma and chronic obstructive pulmonary disease (COPD) become quite crucial and problematic after 65 years of age and hence, requires treatment with the use of nebulizers.
Chronic obstructive pulmonary disease (COPD) is considered to be one of the leading causes of death in developing countries. Geriatric people diagnosed with COPD or any other respiratory disorder such as asthma are more likely to prefer nebulizers instead of liquid medication. This factor is fueling the growth of the global market for nebulizers.
Improvements in diagnostic and treatment services in developing countries are responsible for the rapid growth of the global nebulizers market. There is a rise in the number of people diagnosed with various respiratory disorders such as asthma and COPD globally. A nebulizer is a medical device that can be used for the treatment of respiratory disorders such as asthma, COPD, and cystic fibrosis. It converts liquid medication into mist or aerosol, and drugs can reach the lungs of a patient when inhaled through the mouth or a face mask.
The rapid shift of patients from hospital care devices to home healthcare devices has accelerated the growth of this market. There is also an increasing demand for pneumatic nebulizers from geriatric patients due to their cost-effectiveness compared to ultrasonic and mesh nebulizers.
North America is expected to offer huge revenue opportunities to the nebulizers business during the forecast period. A rise in the prevalence of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis in the region is responsible for the largest market share in North America. Some other factors fueling market growth in the region are technological advancements in healthcare and the increasing adoption of home healthcare facilities.
The nebulizers market in Asia Pacific is anticipated to expand at a rapid rate owing to factors such as the prevalence of respiratory disorders including asthma and bronchitis, growing demand for personalized medicines, rising health awareness, and increasing disposable income. In addition, economic development and healthcare reforms would increase government funding in intensive R&D and would further fuel the growth of the global market for nebulizers in the Asia Pacific.
The COVID-19 pandemic is driving the demand for homecare nebulizers. Due to the pandemic, disease diagnosis and treatment provided at home for patients suffering from severe respiratory complications are driving the demand for nebulizers in developing countries. The home healthcare system is found to be effective for the rapidly growing geriatric population across the globe. Hence, the demand for nebulizers is increasing across the globe.
The coronavirus pandemic has put intense pressure on the global healthcare system. Healthcare practitioners gave priority to critical patients suffering from severe health complications. Moreover, the global nebulizer market is booming after the significant efforts taken by governments, healthcare practitioners, and market stakeholders to recover from losses caused due to the pandemic.
Attribute |
Detail |
Market Size Value in 2020 |
US$ 1 Bn |
Market Forecast Value in 2028 |
US$ 1.7 Bn |
Growth Rate (CAGR) |
6.6% |
Forecast Period |
2021–2028 |
Quantitative Units |
US$ Bn for Value |
Market Analysis |
It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
Product Type
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
Nebulizers Market – Segmentation
Product Type |
|
Region |
|
The global market for Nebulizers is expected to reach the value of US$ 1.7 Bn by the end of 2028
The nebulizers market is estimated to expand at a CAGR of 6.6% from 2021 to 2028
The Nebulizers market is driven by a rise in the prevalence of asthma, COPD, and cystic fibrosis
The pneumatic nebulizers segment accounted for a leading share of the global nebulizers market
Key players in the global nebulizers market include Agilent Technologies, Inc., Allied Healthcare Products, Inc., CareFusion Corporation, Covidien plc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nebulizers Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nebulizers Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Porters Five Forces Analysis
5.3. Key Industry Developments
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Nebulizers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2028
6.3.1. Pneumatic Nebulizer
6.3.1.1. Vented Pneumatic Nebulizers
6.3.1.2. Breath-actuated Pneumatic Nebulizers
6.3.2. Ultrasonic Nebulizers
6.3.2.1. Standalone Ultrasonic Nebulizers
6.3.2.2. Portable Ultrasonic Nebulizers
6.3.3. Mesh Nebulizers
6.3.3.1. Static Mesh Nebulizers
6.3.3.2. Vibrating Mesh Nebulizers
6.4. Market Attractiveness Analysis, by Type
7. Global Nebulizers Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Nebulizers Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017–2028
8.2.1. Pneumatic Nebulizer
8.2.1.1. Vented Pneumatic Nebulizers
8.2.1.2. Breath-actuated Pneumatic Nebulizers
8.2.2. Ultrasonic Nebulizers
8.2.2.1. Standalone Ultrasonic Nebulizers
8.2.2.2. Portable Ultrasonic Nebulizers
8.2.3. Mesh Nebulizers
8.2.3.1. Static Mesh Nebulizers
8.2.3.2. Vibrating Mesh Nebulizers
8.3. Market Value Forecast, by Country, 2017–2028
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Type
8.4.2. By Country
9. Europe Nebulizers Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017–2028
9.2.1. Pneumatic Nebulizer
9.2.1.1. Vented Pneumatic Nebulizers
9.2.1.2. Breath-actuated Pneumatic Nebulizers
9.2.2. Ultrasonic Nebulizers
9.2.2.1. Standalone Ultrasonic Nebulizers
9.2.2.2. Portable Ultrasonic Nebulizers
9.2.3. Mesh Nebulizers
9.2.3.1. Static Mesh Nebulizers
9.2.3.2. Vibrating Mesh Nebulizers
9.3. Market Value Forecast, by Country/Sub-region, 2017–2028
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Type
9.4.2. By Country/Sub-region
10. Asia Pacific Nebulizers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2028
10.2.1. Pneumatic Nebulizer
10.2.1.1. Vented Pneumatic Nebulizers
10.2.1.2. Breath-actuated Pneumatic Nebulizers
10.2.2. Ultrasonic Nebulizers
10.2.2.1. Standalone Ultrasonic Nebulizers
10.2.2.2. Portable Ultrasonic Nebulizers
10.2.3. Mesh Nebulizers
10.2.3.1. Static Mesh Nebulizers
10.2.3.2. Vibrating Mesh Nebulizers
10.3. Market Value Forecast, by Country/Sub-region, 2017–2028
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Type
10.4.2. By Country/Sub-region
11. Latin America Nebulizers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2028
11.2.1. Pneumatic Nebulizer
11.2.1.1. Vented Pneumatic Nebulizers
11.2.1.2. Breath-actuated Pneumatic Nebulizers
11.2.2. Ultrasonic Nebulizers
11.2.2.1. Standalone Ultrasonic Nebulizers
11.2.2.2. Portable Ultrasonic Nebulizers
11.2.3. Mesh Nebulizers
11.2.3.1. Static Mesh Nebulizers
11.2.3.2. Vibrating Mesh Nebulizers
11.3. Market Value Forecast, by Country/Sub-region, 2017–2028
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Nebulizers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2028
12.2.1. Pneumatic Nebulizer
12.2.1.1. Vented Pneumatic Nebulizers
12.2.1.2. Breath-actuated Pneumatic Nebulizers
12.2.2. Ultrasonic Nebulizers
12.2.2.1. Standalone Ultrasonic Nebulizers
12.2.2.2. Portable Ultrasonic Nebulizers
12.2.3. Mesh Nebulizers
12.2.3.1. Static Mesh Nebulizers
12.2.3.2. Vibrating Mesh Nebulizers
12.3. Market Value Forecast, by Country/Sub-region, 2017–2028
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Company Profiles
13.2.1. Agilent Technologies, Inc.
13.2.1.1. Company Overview
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. Business Strategies
13.2.1.5. Recent Developments
13.2.2. Allied Healthcare Products, Inc.
13.2.2.1. Company Overview
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. Business Strategies
13.2.2.5. Recent Developments
13.2.3. CareFusion Corporation
13.2.3.1. Company Overview
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. Business Strategies
13.2.3.5. Recent Developments
13.2.4. Covidien plc
13.2.4.1. Company Overview
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. Business Strategies
13.2.4.5. Recent Developments
13.2.5. GE Healthcare Ltd.
13.2.5.1. Company Overview
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. Business Strategies
13.2.5.5. Recent Developments
13.2.6. GF Health Products, Inc.
13.2.6.1. Company Overview
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. Business Strategies
13.2.6.5. Recent Developments
13.2.7. Omron Healthcare, Inc.
13.2.7.1. Company Overview
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. Business Strategies
13.2.7.5. Recent Developments
13.2.8. PARI Respiratory Equipment, Inc.
13.2.8.1. Company Overview
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. Business Strategies
13.2.8.5. Recent Developments
13.2.9. Philips Healthcare
13.2.9.1. Company Overview
13.2.9.2. Financial Overview
13.2.9.3. Product Portfolio
13.2.9.4. Business Strategies
13.2.9.5. Recent Developments
List of Table
Table 1: Global Nebulizers Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 2: Global Nebulizers Market Size (US$ Mn) Forecast, by Region, 2017–2028
Table 3: North America Nebulizers Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 4: North America Nebulizers Market Size (US$ Mn) Forecast, by Country, 2017–2028
Table 5: Europe Nebulizers Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 6: Europe Nebulizers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 7: Asia Pacific Nebulizers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 8: Latin America Nebulizers Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 9: Latin America Nebulizers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 10: Middle East & Africa Nebulizers Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 11: Middle East & Africa Nebulizers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
List of Figure
Figure 1: Global Nebulizers Market Size (US$ Mn) Forecast, 2017–2028
Figure 2: Global Nebulizers Market Value Share, by Product Type, 2020
Figure 3: Global Nebulizers Market Value Share, by Region, 2020
Figure 4: Global Nebulizers Market Attractiveness Analysis, by Product Type, 2021–2028
Figure 5: Global Pneumatic Nebulizers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 6: Global Ultrasonic Nebulizers Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 7: Global Mesh Nebulizers Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 8: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 9: Global Others (mass spectrometry, etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 10: Global Nebulizers Market Value Share Analysis, by Region, 2017 and 2028
Figure 11: Global Nebulizers Market Attractiveness Analysis, by Region, 2021–2028
Figure 12: North America Nebulizers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 13: North America Nebulizers Market Attractiveness Analysis, by Country, 2021–2028
Figure 14: North America Nebulizers Market Attractiveness Analysis, by Product Type, 2021–2028
Figure 15: North America Market Value Share Analysis, by Country, 2017 and 2028
Figure 16: North America Market Value Share Analysis, by Product Type, 2017 and 2028
Figure 17: Europe Nebulizers Market Size (US$ Mn) Forecast, 2017–2028
Figure 18: Europe Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 19: Europe Nebulizers Market Value Share Analysis, by Product Type, 2017 and 2028
Figure 20: Europe Nebulizers Market Value Share Analysis, by Country, 2017 and 2028
Figure 21: Europe Nebulizers Market Attractiveness Analysis, by Product Type, 2021–2028
Figure 22: Asia Pacific Nebulizers Market Size (US$ Mn) Forecast, 2017–2028
Figure 23: Asia Pacific Nebulizers Market Attractiveness Analysis, by Country, 2021–2028
Figure 24: Asia Pacific Market Value Share Analysis, by Product Type, 2017 and 2028
Figure 25: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2017 and 2028
Figure 26: Asia Pacific Market Attractiveness Analysis, by Product Type, 2021–2028
Figure 27: Latin America Nebulizers Market Size (US$ Mn) Forecast, 2017–2028
Figure 28: Latin America Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 29: Latin America Market Value Share Analysis, by Product Type, 2017 and 2028
Figure 30: Latin America Market Value Share Analysis, by Country, 2017 and 2028
Figure 31: Latin America Market Attractiveness Analysis, by Product Type, 2021–2028
Figure 32: Middle East & Africa Nebulizers Market Size (US$ Mn) Forecast, 2017–2028
Figure 33: Middle East & Africa Nebulizers Market Attractiveness Analysis, by Country, 2021–2028
Figure 34: Middle East & Africa Market Value Share Analysis, by Product Type, 2017 and 2028
Figure 35: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2028
Figure 36: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2021–2028